Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;25 Suppl 1(Suppl 1):e25929.
doi: 10.1002/jia2.25929.

Adaptation and psychometric evaluation of a scale to measure oral pre-exposure prophylaxis-related stigma among key and vulnerable populations in Kenya

Affiliations

Adaptation and psychometric evaluation of a scale to measure oral pre-exposure prophylaxis-related stigma among key and vulnerable populations in Kenya

Kaitlyn Atkins et al. J Int AIDS Soc. 2022 Jul.

Abstract

Introduction: As oral pre-exposure prophylaxis (PrEP) services scale up throughout sub-Saharan Africa (SSA), clients continue to face challenges with sustained PrEP use. PrEP-related stigma has been shown to influence engagement throughout the HIV PrEP care continuum throughout SSA. Validated quantitative measures of PrEP-related stigma in SSA are of critical importance to better understand its impacts at each stage of the HIV PrEP care continuum. This study aimed to psychometrically evaluate a PrEP-related stigma scale for use among key and vulnerable populations in the context of a Kenya national PrEP programme.

Methods: As part of a larger prospective cohort study nested within Kenya's Jilinde programme, this study used baseline data collected from 1135 participants between September 2018 and April 2020. We used exploratory factor analysis to evaluate the factor structure of a PrEP-related stigma scale. We also assessed convergent construct validity of the PrEP-Related Stigma Scale by testing for expected correlations with depression and uptake of HIV services. Finally, we examined the relationship between PrEP-related stigma and key demographic, psychosocial and behavioural characteristics.

Results: We identified four dimensions of PrEP-related stigma: (1) interpersonal stigma, (2) PrEP norms, (3) negative self-image and (4) disclosure concerns. The scale demonstrated strong internal consistency (α = 0.84), was positively correlated with depressive symptoms and negatively correlated with uptake of HIV services. Multivariable regression analysis demonstrated associations between PrEP-related stigma and sex worker identity.

Conclusions: The adapted and validated PrEP-Related Stigma Scale can enable programmes to quantify how PrEP-related stigma and its dimensions may differentially impact outcomes on the HIV PrEP care continuum, evaluate stigma interventions and tailor programmes accordingly. Opportunities exist to validate the scale in other populations and explore further dimensions of PrEP-related stigma.

Keywords: HIV care continuum; HIV prevention; PrEP; key and vulnerable populations; stigma.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Means and standard deviations for PrEP‐related stigma scores by subgroup (n = 1135). (a) Interpersonal stigma subscale; (b) PrEP norms subscale; (c) negative self‐image subscale; and (d) disclosure concerns subscale. Shaded bars represent mean values for each scale per subgroup; error bars represent standard deviations from the mean. In each group (a–d), black (top) bars represent male sex workers (MSW, n = 16); medium grey (second from top) bars represent men who have sex with men (MSM, n = 105); light grey (third from top) bars represent female sex workers (FSW, n = 616); and dark grey (bottom) bars represent adolescent girls and young women (AGYW, n = 303). Possible scores ranged from 0 to 3 for each subscale (a–d). Abbreviations: PHC‐9, Patient Health Questionnaire‐9; PrEP, pre‐exposure prophylaxis.

Similar articles

Cited by

References

    1. Guideline on when to start antiretroviral therapy and on pre‐exposure prophylaxis for HIV. World Health Organization; 2015. - PubMed
    1. Were DK, Musau A, Atkins K, Shrestha P, Reed J, Curran K, et al. Health system adaptations and considerations to facilitate optimal oral pre‐exposure prophylaxis scale‐up in sub‐Saharan Africa. Lancet HIV. 2021;8(8):e511–20. - PMC - PubMed
    1. Nunn AS, Brinkley‐Rubinstein L, Oldenburg CE, Mayer KH, Mimiaga M, Patel R, et al. Defining the HIV pre‐exposure prophylaxis care continuum. AIDS. 2017;31(5):731–4. - PMC - PubMed
    1. Peng P, Su S, Fairley CK, Chu M, Jiang S, Zhuang X, et al. A global estimate of the acceptability of pre‐exposure prophylaxis for HIV among men who have sex with men: a systematic review and meta‐analysis. AIDS Behav. 2018;22(4):1063–74. - PubMed
    1. Muwonge TR, Nsubuga R, Brown C, Nakyanzi A, Bagaya M, Bambia F, et al. Knowledge and barriers of PrEP delivery among diverse groups of potential PrEP users in Central Uganda. PLoS One. 2020;15(10):e0241399. - PMC - PubMed

Publication types

Substances